Immuno Oncology Videos

Michael R. Grunwald, MD, director of the leukemia section in the department of hematologic oncology and blood disorders at the Levine Cancer Institute, Atrium Health, discusses findings from the PLAT-02 trial, which showed that consolidative hematopoietic stem cell transplant after CD19-directed CAR T-cell therapy prolonged leukemia-free survival for certain patients with relapsed or refractory CD19-positive acute lymphoblastic leukemia, particularly those who achieved complete remission after CAR T-cell therapy but remained at risk for relapse with a short term B-cell aplasia derived.